FTC brings first product-hopping claim in Suboxone settlement

As part of a settlement to resolve criminal and civil liability for its marketing of Suboxone, Reckitt Benckiser has agreed to a Federal Trade Commission order to pay $50 million and change conduct that allegedly blocked generic competition to the opioid addiction treatment.

Get unlimited access to all Global Competition Review content